University of California, San Francisco

  Award Total: $31,159,092 # of Awards: 151 Home Page:

Investigators

  Shelley Adler , Ph.D.- Shelley Adler , Ph.D.- Shelley Adler , Ph.D.- Donna Albertson , Ph.D.- Angela Andersen , Ph.D.- Jeffrey Belkora , Ph.D.- Jeffrey Belkora , Ph.D.- Jeffrey Belkora , Ph.D.- Jeffrey Belkora , Ph.D.- Cindy Benod , Ph.D.- Lucy Berlin , M.S.- Yewoubdar Beyene , Ph.D.- Vinona Bhatia , M.D.- Elizabeth Blackburn , Ph.D.- Nancy Boudreau , Ph.D.- Robert Brasch , M.D.- Frances Brodsky , D.Phil.- Lamorna Brown-Swigart , Ph.D.- Nancy Burke , Ph.D.- Beverly Burns , MS, BA,- Michael Campbell , Ph.D.- Michael Campbell , Ph.D.- Michael Campbell , Ph.D.- Michael Campbell , Ph.D.- Michael Campbell , Ph.D.- Christine Case Lo , Ph.D.c- Aubri Charboneau , Ph.D.- Koie Chin , M.D., Ph.D.- Tsui-Ting Ching , Ph.D.- Jonathan Chou , B.S.- Nicola Clegg , - Colin Collins , Ph.D.- Steven Cummings , B.A., M.D.- Suzanne Dibble , D.N.Sc., RN- Suzanne Dibble , D.N.Sc., RN- Lucy East , Ph.D.- Meredith Edwards Wampler , B.H.S.- Mikala Egeblad , Ph.D.- Laura Esserman , M.D.- Laura Esserman , M.D.- Laura Esserman , M.D.- Laura Esserman , M.D.- Andrew Ewald , Ph.D.- Noreen Facione , Ph.D., R.N., F.N.P.- Laura Fejerman , Ph.D.- Laura Fejerman , Ph.D.- Susan Fisher , Ph.D.- Andrei Goga , M.D., Ph.D.- L. Elizabeth Goldman , M.D.- L. Elizabeth Goldman , M.D.- Steven Gregorich , Ph.D.- Kelly Harradine , Ph.D.- Susan Hawkes , Ph.D.- Robert Hiatt , M.D., Ph.D.- Robert Hiatt , M.D., Ph.D.- Robert Hiatt , M.D., Ph.D.- Leslie Hodges Gallagher , Ph.D.- Dai Horiuchi , Ph.D.- H. Huang , D.Sc.- C. Anthony Hunt , Ph.D.- Noelle Huskey Mullin , BA- Shelley Hwang , M.D., MPH- Nola Hylton , Ph.D.- Nola Hylton , Ph.D.- Nabila Jabrane-Ferrat , Ph.D.- Catherine Jacobson , Ph.D.- Stefanie Jeffrey , M.D.- Kuang-Yu Jen , M.D., Ph.D.- Edwin Jocson , BA- Ella Jones , Ph.D.- Galen Joseph , Ph.D.- Galen Joseph , Ph.D.- Verena Kallab , M.D.- Celia Kaplan , Dr.P.H.- Celia Kaplan , Dr.P.H.- Celia Kaplan , Dr.P.H.- Leah Karliner , M.D.- H. Stephen Kaye , Ph.D.- Karla Kerlikowske , M.S., M.D.- Karla Kerlikowske , M.S., M.D.- Catherine Klifa , Ph.D.- Miriam Komaromy , M.D.- Hosein Kouros-Mehr , B.S.- Deanna Kroetz , Ph.D.- Leonard Kusdra , - Peter Kushner , Ph.D.- Peter Kushner , Ph.D.- Marion Lee , Ph.D.- Dale Leitman , M.D., Ph.D.- Dale Leitman , M.D., Ph.D.- Morton Lieberman , Ph.D.- Morton Lieberman , Ph.D.- Morton Lieberman , Ph.D.- Ching-Shwun Lin , Ph.D.- Bob Liu , Ph.D.- Cara Marks , Ph.D.- Wendy Max , Ph.D.- Kimberly McDermott , Ph.D.- Steve McPhee , M.D.- Paul Mills , Ph.D., MPH- Mark Moasser , M.D.- Mark Moasser , M.D.- Mark Moasser , M.D.- Rita Mukhtar , M.D.- Anna Napoles , PhD, MPH- Anna Napoles , PhD, MPH- Anna Napoles , PhD, MPH- Anna Napoles , PhD, MPH- Sara O'Donnell , - Carmen Ortiz , Ph.D.- Carmen Ortiz , Ph.D.- Carmen Ortiz , Ph.D.- Demetrios Papahadjopoulos , Ph.D.- John Park , M.D.- John Park , M.D.- Rena Pasick , DrPH- Nicholas Petrakis , M.D.- Claudia Petritsch , Ph.D.- Richard Price , M.D.- Thomas Robertson , Ph.D.- Steven Rosen , Ph.D.- Hope Rugo , M.D.- Hope Rugo , M.D.- Hope Rugo , M.D.- Hope Rugo , M.D.- Fred Schaufele , Ph.D.- John Shepherd , Ph.D.- John Shepherd , Ph.D.- John Shepherd , Ph.D.- John Shepherd , Ph.D.- John Shepherd , Ph.D.- Marc Shuman , Ph.D.- Lisa Singer , B.S.- Euan Slorach , Ph.D.- Rebecca Smith-Bindman , M.D.- Alex So , BA- Robert Stern , M.D.- Jeonghoon Sun , Ph.D.- Francis Szoka , Ph.D.- Luika Timmerman , Ph.D.- Thea Tlsty , Ph.D.- Thea Tlsty , Ph.D.- Thea Tlsty , Ph.D.- Thea Tlsty , Ph.D.- Thea Tlsty , Ph.D.- Thea Tlsty , Ph.D.- Debasish Tripathy , M.D.- Debasish Tripathy , M.D.- Debasish Tripathy , M.D.- Debasish Tripathy , M.D.- Janice Tsoh , Ph.D.- Laura van't Veer , Ph.D.- Laura van't Veer , Ph.D.- Paul Webb , Ph.D.- Zena Werb , Ph.D.- Zena Werb , Ph.D.- Zena Werb , Ph.D.- Ching Hang Wong , Ph.D.- Tracey Woodruff , - Tracey Woodruff , - Margaret Wrensch , M.P.H., Ph.D.- Margaret Wrensch , M.P.H., Ph.D.- Margaret Wrensch , M.P.H., Ph.D.- Irene Yen , Ph.D.- Irene Yen , Ph.D.- Bauke Ylstra , Ph.D.- Jack Youngren , Ph.D.- Jun Zhang , Ph.D., M.D.- John Ziegler , M.D., M.Sc.- Elad Ziv , M.D.-

Grants

Title[sort] Cycle Award[sort]
UCSF Breast Oncology Program Scientific Retreat 2017 2017 (Cycle 23) $21,021
 Investigator(s): Lamorna Brown-Swigart, Ph.D. 23MB-0001
Latino Community Education Tool on Hereditary Breast Cancer 2017 (Cycle 23) $30,941
 Investigator(s): Laura Fejerman, Ph.D. 23AB-1201
Reducing Breast Cancer Risk in Korean American Women 2017 (Cycle 23) $93,354
 Investigator(s): Janice Tsoh, Ph.D. 23AB-1401
Targeting metastatic TNBC by scavenging blood glutamate 2017 (Cycle 23) $188,680
 Investigator(s): Zena Werb, Ph.D. 23IB-0018
Preventing Tumor Progression in Women with High-Risk DCIS 2016 (Cycle 22) $956,774
 Investigator(s): Thea Tlsty, Ph.D. 22OB-0032
Testing chemicals for likely contribution to breast cancer 2015 (Cycle 21) $1,125,000
 Investigator(s): Susan Fisher, Ph.D. 21UB-8011
Localized Probability of Mammographic Masking 2015 (Cycle 21) $124,112
 Investigator(s): John Shepherd, Ph.D. 21IB-0130
Translating a Stress Management Program for Latinas 2015 (Cycle 21) $942,767
 Investigator(s): Steven Gregorich, Ph.D. 21OB-0135
UCSF Breast Oncology Program Scientific Retreat 2015 (Cycle 21) $12,000
 Investigator(s): Laura van't Veer, Ph.D. 21MB-0004
A Novel TNBC Therapeutic Opportunity: Cystine Addiction 2014 (Cycle 20) $187,330
 Investigator(s): Luika Timmerman, Ph.D. 20IB-0119
Engaging Underserved Women in Health Research 2014 (Cycle 20) $372,139
 Investigator(s): Galen Joseph, Ph.D. 20BB-2100
Breast Cancer and the Human Oral Microbiome 2014 (Cycle 20) $187,221
 Investigator(s): Michael Campbell, Ph.D. 20IB-0103
New Paradigm of Breast Cancer Causation & Prevention-Phase 2 2014 (Cycle 20) $811,840
 Investigator(s): Robert Hiatt, M.D., Ph.D. 20ZB-8303
UCSF Breast Oncology Program Scientific Retreat 2014 (Cycle 20) $8,023
 Investigator(s): Laura van't Veer, Ph.D. 20MB-0001
6th International Workshop on Breast Cancer Risk Assessment 2013 (Cycle 19) $25,000
 Investigator(s): John Shepherd, Ph.D. 19MB-0002
Internal chemical exposure study among Mexican immigrants 2013 (Cycle 19) $124,414
 Investigator(s): Laura Fejerman, Ph.D. 19IB-0147
Meeting the self-care needs of Latinas after breast cancer 2013 (Cycle 19) $191,431
 Investigator(s): Carmen Ortiz, Ph.D. 19AB-2500
Meeting the self-care needs of Latinas after breast cancer 2013 (Cycle 19) $191,431
 Investigator(s): Anna Napoles, PhD, MPH 19AB-2500
Understanding HER3 and mTor Signaling in Breast Cancer 2012 (Cycle 18) $100,000
 Investigator(s): Mark Moasser, M.D. 18IB-0030
Using Epigenetic Changes to Stratify DCIS Biopsies 2012 (Cycle 18) $750,000
 Investigator(s): Thea Tlsty, Ph.D. 18OB-0060
Predicting Breast Cancer Recurrence to Improve Care 2012 (Cycle 18) $793,022
 Investigator(s): Laura Esserman, M.D. 18OB-0065
Genetic Predictors of Chemotherapy Toxicity in Breast Cancer 2012 (Cycle 18) $99,998
 Investigator(s): Deanna Kroetz, Ph.D. 18IB-0027
Compositional Mammography for Breast Cancer Detection 2012 (Cycle 18) $149,895
 Investigator(s): John Shepherd, Ph.D. 18IB-0042
5th International Workshop on Breast Cancer Risk Assessment 2011 (Cycle 17) $20,000
 Investigator(s): John Shepherd, Ph.D. 17MB-0001
Identifying Novel Drugable Targets Against TNBC 2011 (Cycle 17) $150,000
 Investigator(s): Andrei Goga, M.D., Ph.D. 17IB-0024
Clinical Trials Education and Access for Underserved Women 2011 (Cycle 17) $74,875
 Investigator(s): Galen Joseph, Ph.D. 17AB-1500
Biomarkers for environmental exposures in breast cancer 2011 (Cycle 17) $900,000
 Investigator(s): Zena Werb, Ph.D. 17UB-8705
The Role of microRNAs in Triple-Negative Breast Cancer 2010 (Cycle 16) $89,200
 Investigator(s): Leonard Kusdra, 16FB-0044
Targeting Breast Tumor Stem Cells with Cell Cycle Inhibitors 2010 (Cycle 16) $75,981
 Investigator(s): Noelle Huskey Mullin, BA 16GB-0054
Towards Highly Effective Inactivation of HER2-HER3 Signaling 2010 (Cycle 16) $744,957
 Investigator(s): Mark Moasser, M.D. 16OB-0150
Quality of Mammography Facilities Serving Vulnerable Women 2010 (Cycle 16) $238,230
 Investigator(s): L. Elizabeth Goldman, M.D. 16NB-0142
Recording medical visits for people with breast cancer 2010 (Cycle 16) $637,500
 Investigator(s): Jeffrey Belkora, Ph.D. 16BB-1400
Recording medical visits for people with breast cancer 2010 (Cycle 16) $637,500
 Investigator(s): Sara O'Donnell, 16BB-1400
Partnership to Advance Breast Cancer Research 2010 (Cycle 16) $891,518
 Investigator(s): Tracey Woodruff, 16QB-8101
Partnership to Advance Breast Cancer Research 2010 (Cycle 16) $515,121
 Investigator(s): Tracey Woodruff, 16QB-8101A
New Paradigm of Breast Cancer Causation and Prevention 2009 (Cycle 15) $76,968
 Investigator(s): Robert Hiatt, M.D., Ph.D. 15QB-8301A
Targeting MYC in Human Breast Cancer 2009 (Cycle 15) $90,000
 Investigator(s): Dai Horiuchi, Ph.D. 15FB-0006
Diffusion-Weighted MRI in Monitoring Breast Cancer Treatment 2009 (Cycle 15) $48,115
 Investigator(s): Lisa Singer, B.S. 15GB-0013
New Paradigm of Breast Cancer Causation and Prevention 2009 (Cycle 15) $181,995
 Investigator(s): Robert Hiatt, M.D., Ph.D. 15QB-8301
Understanding the Role of GATA3 in Breast Cancer 2009 (Cycle 15) $38,000
 Investigator(s): Jonathan Chou, B.S. 15GB-0012
A Molecular Strategy to Inhibit Breast Cancer Metastasis 2009 (Cycle 15) $150,000
 Investigator(s): Frances Brodsky, D.Phil. 15IB-0035
Compounds Blocking Assembly of LRH-1 in Breast Cancer 2009 (Cycle 15) $90,000
 Investigator(s): Cindy Benod, Ph.D. 15FB-0103
Role of Circadian Rhythm Gene Homolog PER3 in Breast Cancer 2009 (Cycle 15) $45,000
 Investigator(s): Kuang-Yu Jen, M.D., Ph.D. 15FB-0099
Macrophages in Breast Cancer Patients of African Descent 2009 (Cycle 15) $89,518
 Investigator(s): Rita Mukhtar, M.D. 15FB-0108
Breast Cancer Risk Reduction: A Patient-Doctor Intervention 2009 (Cycle 15) $740,685
 Investigator(s): Celia Kaplan, Dr.P.H. 15OB-0158
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas 2009 (Cycle 15) $349,547
 Investigator(s): Anna Napoles, PhD, MPH 15BB-1300
Stratifying DCIS Biopsies for Risk of Future Tumor Formation 2008 (Cycle 14) $750,000
 Investigator(s): Thea Tlsty, Ph.D. 14OB-0165
Neighborhoods and Obesity in Pre-adolescent Girls: Part II 2008 (Cycle 14) $214,406
 Investigator(s): Irene Yen, Ph.D. 14NB-0173
Genetics of Tamoxifen Response 2008 (Cycle 14) $803,111
 Investigator(s): Elad Ziv, M.D. 14OB-0166
Quality of Mammography Facilities Serving Vulnerable Women 2008 (Cycle 14) $150,000
 Investigator(s): L. Elizabeth Goldman, M.D. 14IB-0062
Pesticide and Gene Interactions in Latina Farm Workers 2008 (Cycle 14) $160,718
 Investigator(s): Paul Mills, Ph.D., MPH 14IB-0032
Breast Tumor Responses to Novel TGF-beta Inhibitors 2007 (Cycle 13) $60,521
 Investigator(s): Kelly Harradine, Ph.D. 13FB-0103
Underserved Women with Breast Cancer at End of Life 2007 (Cycle 13) $437,845
 Investigator(s): Shelley Adler, Ph.D. 13BB-1000
A New Mouse Model of PI3-Kinase Induced Breast Cancer 2007 (Cycle 13) $89,600
 Investigator(s): Jun Zhang, Ph.D., M.D. 13FB-0104
Molecular Imaging of Metastatic Lymph Nodes in Breast Cancer 2007 (Cycle 13) $149,600
 Investigator(s): Ella Jones, Ph.D. 13IB-0061
Cytoskeletal Regulation of Invading Breast Cells 2007 (Cycle 13) $20,123
 Investigator(s): Catherine Jacobson, Ph.D. 13FB-0115
Trask, a Candidate Breast Cancer Metastasis Protein 2007 (Cycle 13) $90,000
 Investigator(s): Ching Hang Wong, Ph.D. 13FB-0146
Breast Cancer Treatment Monitoring Combining MRI and Optics 2007 (Cycle 13) $113,166
 Investigator(s): Catherine Klifa, Ph.D. 13IB-0171
Role of Cell Division Asymmetry in Breast Cancer Stem Cells 2006 (Cycle 12) $149,990
 Investigator(s): Claudia Petritsch, Ph.D. 12IB-0140
Increasing Mammography Among Latinas with Disabilities 2006 (Cycle 12) $50,000
 Investigator(s): H. Stephen Kaye, Ph.D. 12AB-2700
Isolation of Cancer Precursors from Normal Human Breasts 2006 (Cycle 12) $45,000
 Investigator(s): Bob Liu, Ph.D. 12FB-0114
Neighborhood Environment and Obesity in Pre-adolescent Girls 2006 (Cycle 12) $162,847
 Investigator(s): Irene Yen, Ph.D. 12IB-0013
Telephone-Based Decision Support for Rural Patients 2006 (Cycle 12) $310,914
 Investigator(s): Jeffrey Belkora, Ph.D. 12BB-3900
Filipina Breast Cancer Support: What Model is Meaningful? 2006 (Cycle 12) $10,000
 Investigator(s): Edwin Jocson, BA 12AB-1800
Filipina Breast Cancer Support: What Model is Meaningful? 2006 (Cycle 12) $10,000
 Investigator(s): Nancy Burke, Ph.D. 12AB-1800
Reactivation of the Inactive X Chromosome and Breast Cancer 2005 (Cycle 11) $48,563
 Investigator(s): Angela Andersen, Ph.D. 11FB-0075
Regulation of Mammary Epithelial Invasion by MMPs and FGFs 2005 (Cycle 11) $135,000
 Investigator(s): Andrew Ewald, Ph.D. 11FB-0015
HER3 Infidelity and Resistance to Tyrosine Kinase Inhibitors 2005 (Cycle 11) $150,000
 Investigator(s): Mark Moasser, M.D. 11IB-0069
Breast Cancer Risk Associated with High Mammographic Density 2005 (Cycle 11) $148,163
 Investigator(s): Thea Tlsty, Ph.D. 11IB-0039
Underserved Women with Breast Cancer at End of Life 2005 (Cycle 11) $56,832
 Investigator(s): Shelley Adler, Ph.D. 11AB-1300
Estrogen Receptor Beta Agonists to Prevent Breast Cancer 2005 (Cycle 11) $150,000
 Investigator(s): Peter Kushner, Ph.D. 11IB-0028
Psychosocial Support Services for Latinas with Breast Cancer 2005 (Cycle 11) $99,200
 Investigator(s): Carmen Ortiz, Ph.D. 11AB-1600
Psychosocial Support Services for Latinas with Breast Cancer 2005 (Cycle 11) $99,200
 Investigator(s): Anna Napoles, PhD, MPH 11AB-1600
Consultation Support for Diverse Rural Breast Patients 2005 (Cycle 11) $38,437
 Investigator(s): Jeffrey Belkora, Ph.D. 11AB-3600
New Breast Cancer Approaches: Integration, Communication 2005 (Cycle 11) $150,000
 Investigator(s): Leah Karliner, M.D. 11IB-0020
Partnership to Reduce Cancer Disparities in Spanish Speakers 2005 (Cycle 11) $55,502
 Investigator(s): Rena Pasick, DrPH 11AB-1800
A Blueprint for Advancing Quality in Breast Cancer 2005 (Cycle 11) $24,586
 Investigator(s): Laura Esserman, M.D. 11MB-0181
Decision Support in Rural Underserved North Coast Counties 2004 (Cycle 10) $40,000
 Investigator(s): Jeffrey Belkora, Ph.D. 10AB-1600
A Novel Approach to Inactivate the Estrogen Receptor 2004 (Cycle 10) $60,000
 Investigator(s): Alex So, BA 10GB-0104
Hox Transcriptional Regulation of Breast Tumor Angiogenesis 2004 (Cycle 10) $30,890
 Investigator(s): Lucy East, Ph.D. 10FB-0166
Epithelial Polarity, Organization and the Angiogenic Switch 2004 (Cycle 10) $75,000
 Investigator(s): Nancy Boudreau, Ph.D. 10IB-0157
Gene Expression Profiling in the Developing Mammary Gland 2004 (Cycle 10) $60,000
 Investigator(s): Hosein Kouros-Mehr, B.S. 10GB-0095
The Functional Implications of Taxane-induced Neuropathy 2004 (Cycle 10) $33,937
 Investigator(s): Meredith Edwards Wampler, B.H.S. 10GB-0001
Socioeconomics and Ethnicity Affect Tumor Endocrine Status 2004 (Cycle 10) $42,117
 Investigator(s): Vinona Bhatia, M.D. 10FB-0191
Assessing Recurrent Genomic Aberrations Linked to Ethnicity 2004 (Cycle 10) $100,000
 Investigator(s): Koie Chin, M.D., Ph.D. 10IB-0195
Protective Role of Estrogen Receptor Beta in Mammary 2004 (Cycle 10) $90,000
 Investigator(s): Leslie Hodges Gallagher, Ph.D. 10FB-0046
Underserved Women with Breast Cancer at End of Life 2004 (Cycle 10) $10,000
 Investigator(s): Shelley Adler, Ph.D. 10AB-1101
Breast Cancer Chemoprevention with Dietary Herbal Estrogens 2004 (Cycle 10) $199,310
 Investigator(s): Dale Leitman, M.D., Ph.D. 10WB-0179
Understanding Herceptin Resistance with Dual Function Array 2003 (Cycle IX) $49,612
 Investigator(s): Tsui-Ting Ching, Ph.D. 9FB-0009
Study of the Apoptotic Phenotype as a Hallmark of Malignancy 2003 (Cycle IX) $155,099
 Investigator(s): Nola Hylton, Ph.D. 9LB-0201
A Novel Predictive Test for Her-2/EGFR Ab-based Therapeutics 2003 (Cycle IX) $79,600
 Investigator(s): Verena Kallab, M.D. 9FB-0088
Novel Genes in Mammary Gland Development and Cancer 2003 (Cycle IX) $80,000
 Investigator(s): Euan Slorach, Ph.D. 9FB-0155
Does Disregulaton of Centrosomes Cause Breast Cancer? 2003 (Cycle IX) $80,000
 Investigator(s): Kimberly McDermott, Ph.D. 9FB-0158
Chinese Herb/Chemotherapy Interactions in Breast Cancer 2003 (Cycle IX) $200,000
 Investigator(s): Michael Campbell, Ph.D. 9WB-0042
Latinas and DCIS: Treatment Decisions and Quality of Life 2003 (Cycle IX) $774,174
 Investigator(s): Celia Kaplan, Dr.P.H. 9PB-0157
The Cost of Breast Cancer in California 2003 (Cycle IX) $315,198
 Investigator(s): Wendy Max, Ph.D. 9PB-0025
Early Transitions in Breast Cancer 2003 (Cycle IX) $199,424
 Investigator(s): Thea Tlsty, Ph.D. 9WB-0107
BCT.org: Feasibility of a Clinical Trial Matching Tool 2003 (Cycle IX) $99,200
 Investigator(s): John Park, M.D. 9DB-0070
BCT.org: Feasibility of a Clinical Trial Matching Tool 2003 (Cycle IX) $99,200
 Investigator(s): Morton Lieberman, Ph.D. 9DB-0070
Racial Disparity in Breast Cancer Mortality 2003 (Cycle IX) $580,887
 Investigator(s): Rebecca Smith-Bindman, M.D. 9PB-0205
Chemotherapy-Induced Ovarian Damage: Prevention and Impact 2002 (Cycle VIII) $64,189
 Investigator(s): Lucy Berlin, M.S. 8AB-1701
Chemotherapy-Induced Ovarian Damage: Prevention and Impact 2002 (Cycle VIII) $64,189
 Investigator(s): Hope Rugo, M.D. 8AB-1701
Drug Dose Tailoring Based on Patient-Specific Factors 2002 (Cycle VIII) $11,827
 Investigator(s): Christine Case Lo, Ph.D.c 8GB-0030
Potential New Drug Therapy for Breast Cancer 2002 (Cycle VIII) $199,740
 Investigator(s): Jack Youngren, Ph.D. 8WB-0099
HOX Transcriptional Regulation of Angiogenesis 2002 (Cycle VIII) $39,029
 Investigator(s): Aubri Charboneau, Ph.D. 8FB-0013
Identification and Prognostic Value of ERb in Breast Cancer 2002 (Cycle VIII) $150,000
 Investigator(s): Dale Leitman, M.D., Ph.D. 8WB-0052
The Role of Matrix Metalloproteinase 13 in Breast Cancer 2002 (Cycle VIII) $80,000
 Investigator(s): Mikala Egeblad, Ph.D. 8FB-0180
Novel Ligands as Probes of Estrogen Receptor Signaling 2002 (Cycle VIII) $50,941
 Investigator(s): Nicola Clegg, 8GB-0025
The Detailed Structure of a Model Breast Cancer Genome 2002 (Cycle VIII) $149,590
 Investigator(s): Colin Collins, Ph.D. 8WB-0054
Breast Stromal Genes Act as Early Markers of Malignancy 2002 (Cycle VIII) $249,624
 Investigator(s): Stefanie Jeffrey, M.D. 8EB-0106
Breast Stromal Genes Act as Early Markers of Malignancy 2002 (Cycle VIII) $249,624
 Investigator(s): Thea Tlsty, Ph.D. 8EB-0106
Targeting Estrogen Receptors to Mouse Mammary Epithelium 2002 (Cycle VIII) $36,027
 Investigator(s): Richard Price, M.D. 8FB-0063
Compositional Breast Density as a Risk Factor 2002 (Cycle VIII) $100,000
 Investigator(s): Steven Cummings, B.A., M.D. 8XB-0146
Compositional Breast Density as a Risk Factor 2002 (Cycle VIII) $100,000
 Investigator(s): Karla Kerlikowske, M.S., M.D. 8XB-0146
Compositional Breast Density as a Risk Factor 2002 (Cycle VIII) $100,000
 Investigator(s): John Shepherd, Ph.D. 8XB-0146
Engineering Antibodies Specific for Breast Cancer Proteases 2001 (Cycle VII) $20,193
 Investigator(s): Jeonghoon Sun, Ph.D. 7FB-0053
Role of Vitamin D Receptor and PI3k Genes in Breast Cancer 2001 (Cycle VII) $0
 Investigator(s): Bauke Ylstra, Ph.D. 7KB-0102
Effectiveness of Internet vs. Face to Face Support Groups 2001 (Cycle VII) $251,763
 Investigator(s): Morton Lieberman, Ph.D. 7BB-1100
Novel Technologies to Identify Tissue-Selective Estrogens 2001 (Cycle VII) $75,000
 Investigator(s): Fred Schaufele, Ph.D. 7IB-0024
In Vivo Effects of Chinese Herbal Extracts on Breast Cancer 2001 (Cycle VII) $199,600
 Investigator(s): Michael Campbell, Ph.D. 7WB-0012
Herba Scutellaria Barbatae for Metastatic Breast Cancer 2001 (Cycle VII) $232,364
 Investigator(s): Hope Rugo, M.D. 7WB-0055
Novel Enzymes Associated with Breast Cancer Angiogensis 2001 (Cycle VII) $100,000
 Investigator(s): Steven Rosen, Ph.D. 7IB-0036
MRI for High Risk Breast Cancer Screening and Surveillance 2000 (Cycle VI) $499,630
 Investigator(s): Nola Hylton, Ph.D. 6EB-0142
MRI for High Risk Breast Cancer Screening and Surveillance 2000 (Cycle VI) $499,630
 Investigator(s): John Ziegler, M.D., M.Sc. 6EB-0142
MRI for High Risk Breast Cancer Screening and Surveillance 2000 (Cycle VI) $499,630
 Investigator(s): Shelley Hwang, M.D., MPH 6EB-0142
Breast Cancer Prevention: The Views of Women and Physicians 2000 (Cycle VI) $434,559
 Investigator(s): Celia Kaplan, Dr.P.H. 6PB-0053
A New Class of Drugs to Treat Breast Cancer 2000 (Cycle VI) $33,694
 Investigator(s): Thomas Robertson, Ph.D. 6FB-0089
Cell-Based Immunotherapy for Breast Cancer 2000 (Cycle VI) $120,811
 Investigator(s): Nabila Jabrane-Ferrat, Ph.D. 6KB-0116
A Patient Decision Support Framework for Breast Cancer 2000 (Cycle VI) $148,400
 Investigator(s): C. Anthony Hunt, Ph.D. 6JB-0100
Targeted Chemotherapy to Treat Breast Cancer 2000 (Cycle VI) $200,000
 Investigator(s): Francis Szoka, Ph.D. 6JB-0137
Chinese Herbal Therapy (CHT) for Symptom Management 2000 (Cycle VI) $200,000
 Investigator(s): Hope Rugo, M.D. 6JB-0118
Pregnancy and Breast Cancer: an Immunological Connection? 2000 (Cycle VI) $74,600
 Investigator(s): Michael Campbell, Ph.D. 6JB-0031
HER2/Neu DNA Vaccines for Breast Cancer 1999 (Cycle V) $197,249
 Investigator(s): Michael Campbell, Ph.D. 5JB-0085
Effectiveness of Electronic Support Groups for Breast Cancer 1999 (Cycle V) $98,605
 Investigator(s): Morton Lieberman, Ph.D. 5JB-0102
Marin County Breast Cancer Study of Adolescent Risk Factors 1999 (Cycle V) $284,868
 Investigator(s): Margaret Wrensch, M.P.H., Ph.D. 5BB-1201
Laboratory Testing of Chinese Herbs Used for Breast Cancer 1999 (Cycle V) $85,754
 Investigator(s): Debasish Tripathy, M.D. 5JB-0068
Beliefs and Risks of Breast Cancer Among African Immigrants 1999 (Cycle V) $236,853
 Investigator(s): Yewoubdar Beyene, Ph.D. 5PB-0027
Marin County Breast Cancer Study of Adolescent Risk Factors 1998 (Cycle IV) $77,407
 Investigator(s): Margaret Wrensch, M.P.H., Ph.D. 4AB-1801
Study of Inadequate Follow-up of Mammographic Abnormalities 1998 (Cycle IV) $10,136
 Investigator(s): Marion Lee, Ph.D. 4AB-2502A
Breast Cancer Risk Factors: Lesbian and Heterosexual Women 1998 (Cycle IV) $186,214
 Investigator(s): Suzanne Dibble, D.N.Sc., RN 4BB-1501
Breast Cancer Risk Factors: Lesbian & Heterosexual Women 1997 (Cycle III) $31,943
 Investigator(s): Suzanne Dibble, D.N.Sc., RN 3AB-2401
Inhibition of Angiogenesis in Breast Cancer 1997 (Cycle III) $67,830
 Investigator(s): Marc Shuman, Ph.D. 3DB-0162
Inhibition of Angiogenesis in Breast Cancer 1997 (Cycle III) $67,830
 Investigator(s): Laura Esserman, M.D. 3DB-0162
Identification of new candidate breast cancer genes 1996 (Cycle II) $186,755
 Investigator(s): Donna Albertson, Ph.D. 2RB-0225A
Targeted gene therapy using anti-pl85HER2 immunoliposomes 1996 (Cycle II) $205,410
 Investigator(s): John Park, M.D. 2CB-0250
Altering telomerase to prevent breast cancer progression 1996 (Cycle II) $44,677
 Investigator(s): Elizabeth Blackburn, Ph.D. 2IB-0077
Architecture of the ErbB2 Molecule Leading to Breast Cancer 1996 (Cycle II) $222,349
 Investigator(s): Cara Marks, Ph.D. 2KB-0114
Harnessing Technology to Improve Mammography Effectiveness 1996 (Cycle II) $370,070
 Investigator(s): Laura Esserman, M.D. 2RB-0024
Mammogram Density,Nipple Aspirate Fluid & Breast Cancer Risk 1996 (Cycle II) $67,821
 Investigator(s): Nicholas Petrakis, M.D. 2RB-0046
TIMP-3, an early indicator of breast cancer? 1996 (Cycle II) $184,537
 Investigator(s): Susan Hawkes, Ph.D. 2RB-0122
Predictors of Recurrent Breast Tumors in Women with DCIS 1996 (Cycle II) $372,771
 Investigator(s): Karla Kerlikowske, M.S., M.D. 2RB-0197
Improved delivery of pharmaceuticals to breast cancer 1996 (Cycle II) $145,492
 Investigator(s): Demetrios Papahadjopoulos, Ph.D. 2CB-0004
Tibetan Medicine for Advanced Breast Cancer 1996 (Cycle II) $53,231
 Investigator(s): Debasish Tripathy, M.D. 2CB-0159
Role of L-Plastin in Breast Cancer 1995 (Cycle I) $304,802
 Investigator(s): Ching-Shwun Lin, Ph.D. 1RB-0316
Promoting Early Detection of Breast Cancer Among Vietnamese 1995 (Cycle I) $298,870
 Investigator(s): Steve McPhee, M.D. 1RB-0343
Role of Estrogen in the Origin of Breast Cancer 1995 (Cycle I) $300,000
 Investigator(s): Peter Kushner, Ph.D. 1RB-0394
The Breast Tumor Suppressor Function of Hyaluronidase 1995 (Cycle I) $302,120
 Investigator(s): Robert Stern, M.D. 1RB-0008
MRI Detection of Microvascular Status in Breast Cancer 1995 (Cycle I) $299,736
 Investigator(s): Robert Brasch, M.D. 1RB-0139
Real Time Telemanagement of Mammography Examinations 1995 (Cycle I) $299,757
 Investigator(s): H. Huang, D.Sc. 1RB-0148
Breast Cancer Incidence in Women with Abnormal Cytology 1995 (Cycle I) $329,176
 Investigator(s): Margaret Wrensch, M.P.H., Ph.D. 1RB-0248
How Women Decide to Seek Evaluation of Breast Symptoms 1995 (Cycle I) $223,588
 Investigator(s): Noreen Facione, Ph.D., R.N., F.N.P. 1KB-0045
Impact of Physician Attitudes on Mammography Screening Rates 1995 (Cycle I) $13,746
 Investigator(s): Miriam Komaromy, M.D. 1KB-0157
Understanding Tamoxifen - A Drug for Breast Cancer 1995 (Cycle I) $225,000
 Investigator(s): Paul Webb, Ph.D. 1KB-0188